Elham Mohit

1.0k total citations
39 papers, 804 citations indexed

About

Elham Mohit is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elham Mohit has authored 39 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elham Mohit's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (10 papers) and Glycosylation and Glycoproteins Research (5 papers). Elham Mohit is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (10 papers) and Glycosylation and Glycoproteins Research (5 papers). Elham Mohit collaborates with scholars based in Iran, Australia and United States. Elham Mohit's co-authors include Sima Rafati, Hossein Vahidi, Azam Bolhassani, Elham Sharif, Mohammad Ali Faramarzi, Farnaz Zahedifard, Nasser Aghdami, Sarah Rajabi, Ensiyeh Hajizadeh‐Saffar and Yasaman Taslimi and has published in prestigious journals such as Vaccine, Journal of Cellular Biochemistry and Archives of Microbiology.

In The Last Decade

Elham Mohit

39 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Mohit Iran 17 402 206 109 104 102 39 804
Eugenio Hardy Cuba 20 682 1.7× 141 0.7× 96 0.9× 91 0.9× 105 1.0× 61 1.1k
Yifan Yu China 7 234 0.6× 249 1.2× 71 0.7× 92 0.9× 49 0.5× 9 610
Zhifang Zhou China 19 701 1.7× 337 1.6× 66 0.6× 87 0.8× 237 2.3× 50 1.1k
Padma Malyala United States 15 637 1.6× 654 3.2× 86 0.8× 132 1.3× 134 1.3× 19 1.2k
Nigel C. Phillips Canada 19 796 2.0× 341 1.7× 117 1.1× 60 0.6× 76 0.7× 41 1.3k
Qiqi Yu China 15 271 0.7× 168 0.8× 108 1.0× 25 0.2× 49 0.5× 33 764
Michael E. Hudson United States 8 555 1.4× 120 0.6× 49 0.4× 45 0.4× 121 1.2× 15 923
Michael D. Swanson United States 17 538 1.3× 328 1.6× 43 0.4× 345 3.3× 58 0.6× 26 1.3k
Joana Dias Portugal 12 222 0.6× 126 0.6× 57 0.5× 25 0.2× 68 0.7× 22 549

Countries citing papers authored by Elham Mohit

Since Specialization
Citations

This map shows the geographic impact of Elham Mohit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Mohit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Mohit more than expected).

Fields of papers citing papers by Elham Mohit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Mohit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Mohit. The network helps show where Elham Mohit may publish in the future.

Co-authorship network of co-authors of Elham Mohit

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Mohit. A scholar is included among the top collaborators of Elham Mohit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Mohit. Elham Mohit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sharif, Elham, et al.. (2024). In Silico Design of CT26 Polytope and its Surface Display by ClearColi™-Derived Outer Membrane Vesicles as a Cancer Vaccine Candidate Against Colon Carcinoma. Applied Biochemistry and Biotechnology. 196(12). 8820–8847. 3 indexed citations
3.
Mohit, Elham, et al.. (2024). Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate. Microbial Pathogenesis. 193. 106749–106749. 5 indexed citations
4.
Sharif, Elham, Navid Nezafat, & Elham Mohit. (2024). Recombinant ClearColi™-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma. International Immunopharmacology. 143(Pt 2). 113283–113283. 3 indexed citations
5.
Shahhosseini, Soraya, et al.. (2024). Preparation, Characterization, and Radiolabeling of Anti‐HER2 scFv With Technetium Tricarbonyl and Stability Studies. Journal of Labelled Compounds and Radiopharmaceuticals. 67(5). 168–179. 3 indexed citations
6.
7.
Mohit, Elham, et al.. (2023). Recent advances in various bio-applications of bacteria-derived outer membrane vesicles. Microbial Pathogenesis. 185. 106440–106440. 7 indexed citations
8.
Sharif, Elham, et al.. (2022). Different strategies for expression and purification of the CT26-poly-neoepitopes vaccine in Escherichia coli. Molecular Biology Reports. 49(2). 859–873. 5 indexed citations
9.
Sharif, Elham, et al.. (2022). The effects of different thermal and chemical stresses on release of outer membrane vesicles (OMVs) by ClearColi™. Archives of Microbiology. 204(12). 714–714. 7 indexed citations
10.
Sharif, Elham, Zohre Eftekhari, & Elham Mohit. (2021). The Effect of Growth Stage and Isolation Method on Properties of ClearColi™ Outer Membrane Vesicles (OMVs). Current Microbiology. 78(4). 1602–1614. 28 indexed citations
11.
Shahhosseini, Soraya, et al.. (2021). Evaluating the efficacy of immobilized metal affinity chromatography (IMAC) for host cell protein (HCP) removal from anti-HER2 scFv expressed in Escherichia coli. Protein Expression and Purification. 190. 106004–106004. 3 indexed citations
12.
Mahboubi, Arash, et al.. (2020). Comparison of Linear Poly Ethylene Imine (LPEI) and Poly L-Lysine (PLL) in Fabrication of CHOK1 Cell-Loaded Multilayer Alginate Microcapsules. Advanced Pharmaceutical Bulletin. 10(2). 290–296. 8 indexed citations
13.
Maleknia, Shayan, et al.. (2020). Optimization of HER2-based and cell-based ELISA for detection of trastuzumab biosimilar. Koomesh Journal. 22(2). 341–350. 2 indexed citations
14.
Mohit, Elham, Maryam Tabarzad, & Mohammad Ali Faramarzi. (2019). Biomedical and Pharmaceutical-Related Applications of Laccases. Current Protein and Peptide Science. 21(1). 78–98. 20 indexed citations
15.
Mohit, Elham, et al.. (2019). Enhanced Solubility of Anti-HER2 scFv Using Bacterial Pelb Leader Sequence. Iranian journal of pharmaceutical sciences. 15(1). 1–16. 5 indexed citations
16.
Behdani, Mahdi, et al.. (2019). Anti-HER2 scFv Expression in Escherichia coli SHuffle®T7 Express Cells: Effects on Solubility and Biological Activity. Molecular Biotechnology. 62(1). 18–30. 32 indexed citations
17.
Mahboubi, Arash, et al.. (2018). Comparison of different cationic polymers efficacy in fabrication of alginate multilayer microcapsules. Asian Journal of Pharmaceutical Sciences. 15(1). 95–103. 22 indexed citations
18.
Ansari, Hassan, et al.. (2018). Exosomes Secreted by Normoxic and Hypoxic Cardiosphere-derived Cells Have Anti-apoptotic Effect.. PubMed. 17(1). 377–385. 18 indexed citations
19.
Mohit, Elham, Azam Bolhassani, Farnaz Zahedifard, et al.. (2012). Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections. Molecular Immunology. 53(1-2). 149–160. 21 indexed citations
20.
Mohit, Elham, Azam Bolhassani, Farnaz Zahedifard, Yasaman Taslimi, & Sima Rafati. (2011). The Contribution of NT‐gp96 as an Adjuvant for Increasing HPV16 E7‐Specific Immunity in C57BL /6 Mouse Model. Scandinavian Journal of Immunology. 75(1). 27–37. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenio Hardy Breakdown of academic impact, for papers by Yifan Yu Breakdown of academic impact, for papers by Zhifang Zhou Breakdown of academic impact, for papers by Padma Malyala Breakdown of academic impact, for papers by Nigel C. Phillips Breakdown of academic impact, for papers by Qiqi Yu Breakdown of academic impact, for papers by Michael E. Hudson Breakdown of academic impact, for papers by Michael D. Swanson Breakdown of academic impact, for papers by Joana Dias
Rankless by CCL
2026